Targeting IGF2BP1 Creates a Mitotic Vulnerability in Colorectal Carcinoma
Bruno Griesler, Sven Hagemann, Robert E. Winkler, Alice Wedler, Claudia Misiak, Danny Misiak, Alexander Rausch, Jana Lützkendorf, Thomas Mueller, Khursheed Ul Islam Mir, Christian H. Ihling, Florian Wolfgang Otto, Andrea Sinz, Jan‐Henning Klusmann, Michael Heuser, , Stefan Hüttelmaier
This study identifies IGF2BP1 as a regulator of mitotic integrity in CRC, showing that its inhibition creates a therapeutic vulnerability that synergizes with paclitaxel.
bioRxiv · Oct 26, 2026 · PreprintCancer Biology